654
Views
16
CrossRef citations to date
0
Altmetric
Original Research

Global Burden of Ischemic Heart Disease and Attributable Risk Factors, 1990–2017: A Secondary Analysis Based on the Global Burden of Disease Study 2017

ORCID Icon, , ORCID Icon, , ORCID Icon, , ORCID Icon & ORCID Icon show all
Pages 859-870 | Published online: 21 Sep 2021

References

  • HartleyA, MarshallDC, SalciccioliJD, SikkelMB, MaruthappuM, ShalhoubJ. Trends in mortality from ischemic heart disease and cerebrovascular disease in Europe:1980 to 2009. Circulation. 2016;133(20):1916–1926. doi:10.1161/CIRCULATIONAHA.115.01893127006480
  • KhanMA, HashimMJ, MustafaH, et al. Global epidemiology of ischemic heart disease: results from the global burden of disease study. Cureus. 2020;12(7):e9349. doi:10.7759/cureus.934932742886
  • MensahGA, RothGA, FusterV. The global burden of cardiovascular diseases and risk factors: 2020 and beyond. J Am Coll Cardiol. 2019;74(20):2529–2532. doi:10.1016/j.jacc.2019.10.00931727292
  • LiuS, LiY, ZengX, et al. Burden of cardiovascular diseases in China, 1990–2016: findings from the 2016 Global Burden of Disease Study. JAMA Cardiol. 2019;4(4):342–352. doi:10.1001/jamacardio.2019.029530865215
  • India State-Level Disease Burden Initiative CVD Collaborators. The changing patterns of cardiovascular diseases and their risk factors in the states of India: the Global Burden of Disease Study 1990–2016. Lancet Glob Health. 2018;6(12):e1339–e1351. doi:10.1016/S2214-109X(18)30407-830219317
  • YusufS, RangarajanS, TeoK, et al. Cardiovascular risk and events in 17 low-, middle-, and high-income countries. N Engl J Med. 2014;371(9):818–827. doi:10.1056/NEJMoa131189025162888
  • LanasF, SerónP, LanasA. Coronary heart disease and risk factors in latin america. Glob Heart. 2013;8(4):341–348. doi:10.1016/j.gheart.2013.11.00525690636
  • MendozaW, MirandaJJ. Global shifts in cardiovascular disease, the epidemiologic transition, and other contributing factors: toward a new practice of global health cardiology. Cardiol Clin. 2017;35(1):1–12. doi:10.1016/j.ccl.2016.08.00427886780
  • RothGA, JohnsonC, AbajobirA, et al. Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015. J Am Coll Cardiol. 2017;70(1):1–25. doi:10.1016/j.jacc.2017.04.05228527533
  • MoranAE, OliverJT, MirzaieM, et al. Assessing the global burden of ischemic heart disease: part 1: methods for a systematic review of the global epidemiology of ischemic heart disease in 1990 and 2010. Glob.Heart. 2012;7(4):315–329. doi:10.1016/j.gheart.2012.10.00423682350
  • MoranAE, TzongKY, ForouzanfarMH, et al. Variations in ischemic heart disease burden by age, country, and income: the global burden of diseases, injuries, and risk factors 2010 study. Glob.Heart. 2014;9(1):91–99. doi:10.1016/j.gheart.2013.12.00724977114
  • GBD 2016 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural,environmental and occupational, and metabolic risks or clusters of risks,1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1345–1422. doi:10.1016/S0140-6736(17)32366-828919119
  • GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence,and years lived with disability for 354 diseases and injuries for 195 countries and territories,1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1789–1858. doi:10.1016/S0140-6736(18)32279-730496104
  • GBD 2017 Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories,1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1736–1788. doi:10.1016/S0140-6736(18)32203-730496103
  • MurrayCJ, EzzatiM, FlaxmanAD, et al. GBD 2010: design, definitions, and metrics. Lancet. 2013;380(9859):2063–2066. doi:10.1016/S0140-6736(12)61899-6
  • ForemanKJ, LozanoR, LopezAD, MurrayCJ. Modeling causes of death: an integrated approach using CODEm. Popul.Health.Metr. 2012;10(1):1–23. doi:10.1186/1478-7954-10-122226226
  • GBD 2017 DALYs and HALE Collaborators. Global, regional,and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories,1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1859–1922. doi:10.1016/S0140-6736(18)32335-330415748
  • GBD 2017 Population and Fertility Collaborators. Population and fertility by age and sex for 195 countries and territories,1950–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1995–2051. doi:10.1016/S0140-6736(18)32278-530496106
  • VosT, FlaxmanAD, NaghaviM, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2163–2196. doi:10.1016/S0140-6736(12)61729-223245607
  • GwonJG, ChoiJ, HanYJ. Community-level socioeconomic inequality in the incidence of ischemic heart disease: a nationwide cohort study. BMC Cardiovasc Disord. 2020;20(1):87. doi:10.1186/s12872-020-01389-132087693
  • MokdadAH, ForouzanfarMH, DaoudF, et al. Health in times of uncertainty in the eastern Mediterranean region,1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet Glob Health. 2016;4(10):e704–e713. doi:10.1016/S2214-109X(16)30168-127568068
  • MensahGA. Ischaemic heart disease in Africa. Heart. 2008;94:836–843. doi:10.1136/hrt.2008.14277818552223
  • BrinkAJ, AalbersJ. Strategies for heart disease in sub-Saharan Africa. Heart. 2009;95:1559–1560. doi:10.1136/hrt.2009.17574519628470
  • YuyunMF, SliwaK, KengneAP, MocumbiAO, BukhmanG. Cardiovascular diseases in sub-saharan Africa compared to high-income countries: an epidemiological perspective. Glob Heart. 2020;15(1):15. doi:10.5334/gh.40332489788
  • WalkerAR, SareliP. Coronary heart disease: outlook for Africa. J R Soc Med. 1997;90(1):23–27. doi:10.1177/014107689709000108
  • MensahGA, RothGA, SampsonUK, et al. Mortality from cardiovascular diseases in sub-Saharan Africa,1990–2013: a systematic analysis of data from the Global Burden of Disease Study 2013. Cardiovasc.J.Afr. 2015;26(2 Suppl1):S6–S10. doi:10.5830/CVJA-2015-03625962950
  • FrostMJ, TranJB, KhatunF, FribergIK, RodríguezDC. What does it take to be an effective national steward of digital health integration for health systems strengthening in low-and middle-income countries?Glob Health Sci Pract. 2018;6(Suppl1):S18–S28. doi:10.9745/GHSP-D-18-0027030305336
  • MurphyA, JohnsonCO, RothGA, et al. Ischaemic heart disease in the former Soviet Union 1990–2015 according to the Global Burden of Disease 2015 Study. Heart. 2018;104(1):58–66. doi:10.1136/heartjnl-2016-31114228883037
  • RobertsB, StickleyA, BalabanovaD, HaerpferC, McKeeM. The persistence of irregular treatment of hypertension in the former Soviet Union. J Epidemiol Community Health. 2012;66(11):1079–1082. doi:10.1136/jech-2011-20064522447959
  • GBD Compare(Viz Hub) [homepage on the Internet]. Institute for Health Metrics and Evaluation (IHME). Available from: http://ihmeuw.org/5j7h. Accessed 82, 2021.
  • LangeS, VollmerS. The effect of economic development on population health: a review of the empirical evidence. Br Med Bull. 2017;121(1):47–60. doi:10.1093/bmb/ldw05228069615
  • NowbarAN, GittoM, HowardJP, FrancisDP, Al-LameeR. Mortality from ischemic heart disease. Circ Cardiovasc Qual Outcomes. 2019;12(6):e005375. doi:10.1161/CIRCOUTCOMES.118.00537531163980
  • KotsevaK, De BackerG, De BacquerD, et al. Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry. Eur J Prev Cardiol. 2019;26(8):824–835. doi:10.1177/204748731882535030739508
  • PopovaS, RehmJ, PatraJ, ZatonskiW. Comparing alcohol consumption in central and eastern Europe to other European countries. Alcohol Alcohol. 2007;42(5):465–473. doi:10.1093/alcalc/agl12417287207
  • CeciFM, CeccantiM, PetrellaC, et al. Alcohol drinking, apolipoprotein polymorphisms and the risk of cardiovascular diseases. Curr Neurovasc Res. 2021;18(1):150–161. doi:10.2174/156720261866621040612350333823779
  • Household spending on alcohol close to €130 billion [homepage on the Internet]. European Commission, Eurostatl. Available from: https://ec.europa.eu/eurostat/en/web/products-eurostat-news/-/ddn-20190101-1. Accessed 11, 2019.
  • GinterE. Cardiovascular disease prevention in eastern Europe. Nutrition. 1998;14(5):452–457. doi:10.1016/s0899-9007(98)00017-39614311
  • MahmoodSS, LevyD, VasanRS, WangTJ. The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective. Lancet. 2014;383(9921):999–1008. doi:10.1016/S0140-6736(13)61752-324084292
  • DaiH, MuchAA, MaorE, et al. Global, regional, and national burden of ischemic heart disease and its attributable risk factors, 1990–2017: results from the global Burden of Disease Study 2017. Eur Heart J Qual Care Clin Outcomes. 2020:qcaa076. doi:10.1093/ehjqcco/qcaa07633017008
  • PolinderS, HaagsmaJA, SteinC, HavelaarAH. Systematic review of general burden of disease studies using disability-adjusted life years. Popul Health Metr. 2012;10(1):21. doi:10.1186/1478-7954-10-2123113929
  • LewingtonS, ClarkeR, QizilbashN, PetoR, CollinsR; Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360(9349):1903–1913. doi:10.1016/s0140-6736(02)11911-812493255
  • LawesCM, BennettDA, LewingtonS, RodgersA. Blood pressure and coronary heart disease: a review of the evidence. Semin Vasc Med. 2002;2(4):355–368. doi:10.1055/s-2002-3676516222626
  • NCD Risk Factor Collaboration. Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants. Lancet. 2017;389(10064):37–55. doi:10.1016/S0140-6736(16)31919-527863813
  • MillsKT, StefanescuA, HeJ. The global epidemiology of hypertension. Nat Rev Nephrol. 2020;16(4):223–237. doi:10.1038/s41581-019-0244-232024986
  • BhupathirajuSN, HuFB. Epidemiology of obesity and diabetes and their cardiovascular complications. Circ Res. 2016;118(11):1723–1735. doi:10.1161/CIRCRESAHA.115.30682527230638
  • YuITS, LiW, WongTW. Effects of age, period and cohort on acute myocardial infarction mortality in Hong Kong. Int J Cardiol. 2004;97(1):63–68. doi:10.1016/j.ijcard.2003.07.03215336808
  • CapraraG. Mediterranean-type dietary pattern and physical activity: the winning combination to counteract the rising burden of non-communicable diseases (NCDs). Nutrients. 2021;13(2):429. doi:10.3390/nu1302042933525638
  • PrescottE, ScharlingH, OslerM, SchnohrP. Importance of light smoking and inhalation habits on risk of myocardial infarction and all cause mortality. A 22 year follow up of 12149 men and women in the Copenhagen City Heart Study. J Epidemiol Community Health. 2002;56(9):702–706. doi:10.1136/jech.56.9.70212177089
  • HeydariG, ZaatariG, Al-LawatiJA, et al. MPOWER, needs and challenges: trends in the implementation of the WHO FCTC in the Eastern Mediterranean Region. East Mediterr Health J. 2018;24(1):63–71. doi:10.26719/2018.24.1.6329658622
  • World Health Organization. WHO Global Report on Trends in the Prevalence of tobacco use 2000–2025, third edition. Geneva; 2019.
  • LundKE, LundM, BryhniA. Tobacco consumption among men and women 1927–2007. Tidsskr nor Laegeforen. 2009;129(18):1871–1874. doi:10.4045/tidsskr.08.024819844280
  • SlamaK. Global perspective on tobacco control. Part I. The global state of the tobacco epidemic. Int J Tuberc Lung Dis. 2008;12(1):3–7.18173869
  • JohnsonNB, HayesLD, BrownK, et al. CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors–United States, 2005–2013. MMWR Suppl. 2014;63(4):3–27.
  • MokdadAH, MarksJS, StroupDF, GerberdingJL. Actual causes of death in the United States, 2000. JAMA. 2004;291(10):1238–1245. doi:10.1001/jama.291.10.123815010446
  • PhillipsDE, LozanoR, NaghaviM, et al. A composite metric for assessing data on mortality and causes of death: the vital statistics performance index. Popul Health Metr. 2014;12:14. doi:10.1186/1478-7954-12-1424982595